Jeffrey LaRose, Chief Scientific Officer at HeartWare International, Inc. (HTWR), sold 15,342 shares at $100.00 ($1.5M) on 2014-01-07, disclosed to the SEC on 2014-01-07.
Scheduled sale ($1.5M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| HTWR | SELL | 2016-02-09 | $20K | — | Filing → |
| HTWR | SELL | 2015-12-23 | $57K | — | Filing → |
| HTWR | SELL | 2015-02-26 | $30K | — | Filing → |